This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
Novamoxin (2016-08-18)
- Starting date:
- August 18, 2016
- Posting date:
- September 20, 2016
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type III
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-60218
Affected Products
Novamoxin
Reason
Product does not meet the stability specification for homogeneity
Depth of distribution
Pharmacies and Wholesalers
Alberta, British Columbia, Manitoba, Saskatchewan, New Brunswick, Newfoundland, Ontario
and Quebec.
Affected products
Novamoxin
DIN, NPN, DIN-HIM
DIN 00452149Dosage form
Granules for suspension
Strength
125 mg / 5 mL
Lot or serial number
35434290A
Companies
- Recalling Firm
-
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
- Marketing Authorization Holder
-
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA